Conmed (CNMD) Tops Q2 EPS by 1c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
CONMED Corporation Announces Second Quarter 2018 Financial Results
August 1, 2018 4:01 PM EDTUTICA, N.Y.--(BUSINESS WIRE)-- CONMED Corporation (Nasdaq: CNMD) today announced financial results for the second quarter ended June 30, 2018.
Second Quarter 2018 Highlights
Sales of $212.8 million increased 7.9% year over year as reported and 7.4% in constant currency and as adjusted(1). Domestic revenue increased 9.6% year over year as reported and 12.0% as adjusted(1). International revenue increased 6.2% as reported and 2.9% in constant currency. Gross margin (GAAP) increased 150 basis points and adjusted gross margin increased 190 basis points year over year to... More